Schram A W, Brouwer-Kelder B, Donker-Koopman W E, Loonen C, Hamers M N, Tager J M
Biochim Biophys Acta. 1979 Apr 12;567(2):370-83. doi: 10.1016/0005-2744(79)90123-2.
(1) A simple method is described for the isolation of the lysosomal enzyme, acid alpha-glucosidase (alpha-D-glucoside glucohydrolase, EC 3.2.1.20) from normal human liver. Antibodies raised against the purified enzyme were immobilized by covalent coupling to Sepharose 4B. (2) Acid alpha-glucosidase can be quantitatively removed from normal urine by incubating with an excess of immobilized antibody. With p-nitrophenyl-alpha-glucoside as substrate, acid alpha-glucosidase accounts for 91 +/- 3% of the total alpha-glucosidase activity at pH 4.0 IN Normal urine. (3) In urine from a patient with the infantile form of Pompe's disease ('acid maltase deficiency'), no alpha-glucosidase activity could be removed by the immobilized antibody, in agreement with the fact that acid alpha-glucosidase is absent in these patients. (4) In urine from patients with the late-onset form of Pompe's disease, 46 +/- 11% of the alpha-glucosidase activity at pH 4.0 can be removed by incubation with immobilized antibodies, indicating that residual acid alpha-glucosidase activity is present in urine of these patients. The residual acid alpha-glucosidase activity amounts to about 5% of that in the urine of control persons. (5) If acid alpha-glucosidase is adsorbed to immobilized antibodies, the activity can still be measured with p-nitrophenyl-alpha-glucoside as substrate. The Km for p-nitrophenyl-alpha-glucoside is not significantly changed by adsorbing purified acid alpha-glucosidase to immobilized antibodies. (6) The properties of acid alpha-glucosidase from urine of patients with late-onset Pompe's disease were compared with those of acid alpha-glucosidase from normal urine, both adsorbed to immobilized antiserum. The pH-activity profile of the enzyme from urine of patients with late-onset Pompe's disease can not be distinguished from that of the normal urinary enzyme. The Km for p-nitro-phenyl-alpha-glucoside of the two enzymes is identical, both at pH 4 and 3. The titration curves of the two enzymes with immobilized antibodies are identical.
(1) 本文描述了一种从正常人肝脏中分离溶酶体酶酸性α-葡萄糖苷酶(α-D-葡萄糖苷葡糖水解酶,EC 3.2.1.20)的简单方法。通过与琼脂糖4B共价偶联,固定化针对纯化酶产生的抗体。(2) 通过与过量的固定化抗体孵育,可从正常尿液中定量去除酸性α-葡萄糖苷酶。以对硝基苯基-α-葡萄糖苷为底物,在pH 4.0时,酸性α-葡萄糖苷酶占正常尿液中总α-葡萄糖苷酶活性的91±3%。(3) 在患有婴儿型庞贝病(“酸性麦芽糖酶缺乏症”)患者的尿液中,固定化抗体无法去除任何α-葡萄糖苷酶活性,这与这些患者中不存在酸性α-葡萄糖苷酶的事实相符。(4) 在患有晚发型庞贝病患者尿液中,通过与固定化抗体孵育,在pH 4.0时,46±11%的α-葡萄糖苷酶活性可被去除,这表明这些患者尿液中存在残余的酸性α-葡萄糖苷酶活性。残余酸性α-葡萄糖苷酶活性约为对照人员尿液中该酶活性的5%。(5) 如果酸性α-葡萄糖苷酶吸附到固定化抗体上,仍可用对硝基苯基-α-葡萄糖苷作为底物来测量其活性。将纯化的酸性α-葡萄糖苷酶吸附到固定化抗体上后,对硝基苯基-α-葡萄糖苷的Km没有显著变化。(6) 将晚发型庞贝病患者尿液中的酸性α-葡萄糖苷酶与正常尿液中的酸性α-葡萄糖苷酶吸附到固定化抗血清后的性质进行了比较。晚发型庞贝病患者尿液中该酶的pH-活性曲线与正常尿液酶的无法区分。两种酶在pH 4和pH 3时对硝基苯基-α-葡萄糖苷的Km相同。两种酶与固定化抗体的滴定曲线相同。